Filed: 2/14/2025ACC: 0001802630-25-000003
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 81 equity positions with a total reported market value of $1.59B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
81
Positions
$1.59B
Total AUM (reported)
121.31M
Total Shares
Allocation by class
COM$856.46M53.8%
S&P BIOTECH$270.18M17.0%
COM NEW$144.03M9.1%
ORD SHS$81.64M5.1%
SPONSORED ADR$63.33M4.0%
SPONSORED ADS$62.67M3.9%
SP ADR REP B NVT$49.14M3.1%
Portfolio Concentration
Top 3$432.53M27.2%
4–10$359.61M22.6%
11–25$430.61M27.1%
Rest$368.48M23.2%
Top 3 weight
27.2%
Top 10 weight
49.8%
Voting Authority Distribution
Total shares with voting rights: 121.31M
Sole
Full voting authority
121.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole81
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings81
Rows:
SPDR SER TR
SOLEShares3M
TypeSH
Market value$270.18M
16.98%
Sole
3M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares2.74M
TypeSH
Market value$81.64M
5.13%
Sole
2.74M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares2.68M
TypeSH
Market value$80.71M
5.07%
Sole
2.68M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares1M
TypeSH
Market value$65.82M
4.14%
Sole
1M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares358.38K
TypeSH
Market value$56.14M
3.53%
Sole
358.38K
Shared
0.00
None
0.00
GRIFOLS S A
SOLEShares6.61M
TypeSH
Market value$49.14M
3.09%
Sole
6.61M
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares2.96M
TypeSH
Market value$48.71M
3.06%
Sole
2.96M
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares6.56M
TypeSH
Market value$48.54M
3.05%
Sole
6.56M
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares2.09M
TypeSH
Market value$46.13M
2.90%
Sole
2.09M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares8.14M
TypeSH
Market value$45.11M
2.83%
Sole
8.14M
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares12.48M
TypeSH
Market value$39.95M
2.51%
Sole
12.48M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares2.10M
TypeSH
Market value$39.62M
2.49%
Sole
2.10M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares109.39K
TypeSH
Market value$38.60M
2.43%
Sole
109.39K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.57M
TypeSH
Market value$33.58M
2.11%
Sole
2.57M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares2.49M
TypeSH
Market value$32.94M
2.07%
Sole
2.49M
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares1.49M
TypeSH
Market value$31.95M
2.01%
Sole
1.49M
Shared
0.00
None
0.00
INTEGRA LIFESCIENCES HLDGS C
SOLEShares1.28M
TypeSH
Market value$28.94M
1.82%
Sole
1.28M
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.43M
TypeSH
Market value$27.23M
1.71%
Sole
2.43M
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares409K
TypeSH
Market value$26.80M
1.68%
Sole
409K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares6.98M
TypeSH
Market value$25.12M
1.58%
Sole
6.98M
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares547.08K
TypeSH
Market value$24.37M
1.53%
Sole
547.08K
Shared
0.00
None
0.00
INSMED INC
SOLEShares320.27K
TypeSH
Market value$22.11M
1.39%
Sole
320.27K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares6.33M
TypeSH
Market value$20.56M
1.29%
Sole
6.33M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares144K
TypeSH
Market value$19.82M
1.25%
Sole
144K
Shared
0.00
None
0.00
RIGEL PHARMACEUTICALS INC
SOLEShares1.13M
TypeSH
Market value$19.02M
1.20%
Sole
1.13M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 3M | SH | $270.18M 16.98% | 3M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | ORD SHS | 2.74M | SH | $81.64M 5.13% | 2.74M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 2.68M | SH | $80.71M 5.07% | 2.68M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 1M | SH | $65.82M 4.14% | 1M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 358.38K | SH | $56.14M 3.53% | 358.38K | 0.00 | 0.00 |
GRIFOLS S ASOLE | SP ADR REP B NVT | 6.61M | SH | $49.14M 3.09% | 6.61M | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 2.96M | SH | $48.71M 3.06% | 2.96M | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 6.56M | SH | $48.54M 3.05% | 6.56M | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 2.09M | SH | $46.13M 2.90% | 2.09M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 8.14M | SH | $45.11M 2.83% | 8.14M | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 12.48M | SH | $39.95M 2.51% | 12.48M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 2.10M | SH | $39.62M 2.49% | 2.10M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 109.39K | SH | $38.60M 2.43% | 109.39K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.57M | SH | $33.58M 2.11% | 2.57M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 2.49M | SH | $32.94M 2.07% | 2.49M | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 1.49M | SH | $31.95M 2.01% | 1.49M | 0.00 | 0.00 |
INTEGRA LIFESCIENCES HLDGS CSOLE | COM NEW | 1.28M | SH | $28.94M 1.82% | 1.28M | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 2.43M | SH | $27.23M 1.71% | 2.43M | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 409K | SH | $26.80M 1.68% | 409K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 6.98M | SH | $25.12M 1.58% | 6.98M | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 547.08K | SH | $24.37M 1.53% | 547.08K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 320.27K | SH | $22.11M 1.39% | 320.27K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 6.33M | SH | $20.56M 1.29% | 6.33M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 144K | SH | $19.82M 1.25% | 144K | 0.00 | 0.00 |
RIGEL PHARMACEUTICALS INCSOLE | COM | 1.13M | SH | $19.02M 1.20% | 1.13M | 0.00 | 0.00 |
Page 1 of 4